The largest database of trusted experimental protocols

Egf recombinant human protein

Manufactured by Thermo Fisher Scientific
Sourced in United States

EGF recombinant human protein is a laboratory reagent produced by Thermo Fisher Scientific. It is a purified form of the epidermal growth factor (EGF) protein, which is a signaling molecule involved in cellular growth and differentiation. The core function of this product is to serve as a tool for researchers studying cellular processes related to EGF signaling in various experimental systems.

Automatically generated - may contain errors

17 protocols using egf recombinant human protein

1

Culturing Diverse Melanoma and Breast Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
SK-MEL-28, WM164, WM793, and WM266-4 cell lines were a gift from Peter Leedman, and they were cultured in RPMI-1640 medium without phenol red (produced by the Harry Perkins Institute of Medical Research, Perth, Australia; formulated to ATCC specifications), supplemented with 10% heat-inactivated HyClone fetal bovine serum (FBS; GE Healthcare Life Sciences, Chicago, IL) and 1% antibiotic-antimycotic (Anti-Anti; Gibco, Fisher Scientific, Hampton, NH). Normal human melanocytes were a gift from Mel Ziman, and they were cultured in melanocyte growth medium M2 (PromoCell, Heidelberg, Germany). SUM159 cells were cultured in F-12 Nutrient Mixture (Gibco) supplemented with 5% FBS, 0.6% 1 M HEPES (Gibco), 5 μg/mL insulin, human recombinant, zinc solution (Gibco), 1 μg/mL hydrocortisone (Merck, Kenilworth, NJ), and 1% Anti-Anti. MCF-10A cells were cultured in DMEM/F-12 medium (Gibco), supplemented with 5% Normal Horse Serum (Life Technologies, Carlsbad, CA), 20 ng/mL EGF Recombinant Human Protein (Gibco), 0.01 mg/mL insulin, human recombinant, zinc solution, 500 ng/mL hydrocortisone, 100 ng/mL cholera toxin (Sigma-Aldrich, St. Louis, MO), and 1% Anti-Anti. BT-549, ZR-75-1, and MDA-MB-468 cell lines were cultured in RPMI-1640 medium supplemented with 10% FBS and 1% Anti-Anti.
+ Open protocol
+ Expand
2

Investigating EGF Signaling Dynamics

Check if the same lab product or an alternative is used in the 5 most similar protocols
shCT, shHrs, and shTsg101 cells were preincubated for 1 h in growth medium in presence of 10 μg/mL of cycloheximide. Cells were then cultured in growth medium in presence of cycloheximide (10 μg/mL) and with EGF Recombinant Human protein (50 ng/mL; Gibco) for 15, 60, and 120 min. After these time points, cells were recovered and analyzed by Western blotting.
+ Open protocol
+ Expand
3

Synthesis and Characterization of Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols
Gold (III) chloride trihydrate, Silver Nitrate, L-ascorbic Acid, Hyaluronic Acid, Rosmarinic Acid (RA), Oleic Acid, Holo-Transferrin human (powder, grade 97%), and Lapatinib (98%) were acquired from Sigma-Aldrich (St. Louis, MO, USA). EGF Recombinant Human Protein was supplied from Gibco (ThermoFisher Scientific, Waltham, MA, USA). Bradford Dye Reagent was purchased from Alfa Aesar (ThermoFisher Scientific, Waltham, MA, USA). Water MilliQ by Merck Millipore (Burlington, MA, USA). All chemical products and solvents used were of analytical purity grade.
+ Open protocol
+ Expand
4

Cell Line Characterization and Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lines were obtained, authenticated, and cultured as recommended by the American Type Culture Collection (ATCC). All cell lines were tested and negative for mycoplasma. H1975 (EGFRL858R, T790M), A549 (KRASG12S), HCC364 (BRAFV600E), H3122 (EML4-ALK variant 1), and AGS cells were obtained from ATCC. H1975 10-1 and H1975 1-1 metastatic derivatives were obtained from Clovis Oncology and renamed H1975 M1 and H1975 M2, respectively, both were engineered as previously described2 . All cell lines were maintained at 37 °C in a humidified atmosphere at 5% CO2 and grown RPMI 1640 media supplemented with 10% FBS, 100 IU/ml penicillin and 100ug/ml streptomycin.
Rociletinib was obtained from Clovis. EGF recombinant human protein was obtained from ThermoFisher.
+ Open protocol
+ Expand
5

Neural Cell Culture Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dulbecco’s modified Eagle Medium (DMEM), neural basal medium, B27 supplement, KnockOut™ DMEM/F-12 medium, StemPro™ Neural Supplement, StemPro Accutase, FGF-basic (AA 10–155) recombinant human Protein, EGF Recombinant Human Protein were purchased from ThermoFisher Canada. Modified ITS culture supplement was purchased from Wisent Canada., Poly-D-lysin and laminin were obtained from Sigma-Aldrich (St.Louis, MO, USA). The antibodies used were as follows: Antibodies: Anti-MAP2 antibody: Abcam Cat# ab28032; Anti-MeCP2 antibody: Abcam Cat# ab2828; Anti-PDGFR-alpha: Abcam Cat# ab96569; Anti-Myelin Basic Protein antibody: Abcam Cat# ab218011; Anti-GFAP Antibody: ThermoFisher Scientific Cat# PA1-10004; Anti-Neurofilament H (NF-H), Phosphorylated antibody: BioLegend Cat# 801602; Anti-beta-actin antibody: Novus Cat# NB100-56874; Anti-beta 3 Tubulin antibody: Santa Cruz Biotechnology Cat# sc-80005. Timed pregnant Sprague–Dawley rats were obtained from Central Animal Care Services at the University of Manitoba. Animals were housed under temperature-controlled conditions with a 12 hours light/dark cycle and ad libitum access to water and food. All efforts were made to minimize animal suffering and reduce the number of animals used.
+ Open protocol
+ Expand
6

Conjugation of EGF to Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols
EGF Recombinant Human Protein (ThermoFisher, 1mg/mL, 1X PBS) was functionalized by adding 2% v/v of Propargyl-N-hydroxysuccinimidyl ester (Sigma-Aldrich, 0.44 M in DMSO, wt 225.20 g) and incubated on ice for 6 h. The functionalized EGF was then dialyzed in 1x PBS via D-Tube Dialyzers (Millipore) overnight to remove excessive NHS ester. The conjugation was completed by mixing 5 μL of functionalized EGF with membrane-wrapped NP (NP: EGF, 1:50000). The catalyst was prepared by mixing a 0.10 M solution of L-Ascorbic acid with a 5.10 mM solution of CuSO4·5H2O (1:1 v/v). And 3 μL of catalyst was added to the mixture of alkyne-functionalized EGF and azide-presenting NP. The final volume of the mixture was brought to 100 μL with 0.1x PBS. To generate NP-EGF with different EGF loading, membrane-wrapped NP with different wrapping times were used (Figure S5). The crosslinking reaction was maintained at room temperature overnight. Subsequently, excessive EGF and catalyst were removed by dialysis with Nuclepore Track-Etched Membranes (Whatman, Pore Size 0.03 μm, Diameter 25 mm) in 0.1x PBS overnight.
+ Open protocol
+ Expand
7

Breast Cancer Spheroid Culture and Enrichment

Check if the same lab product or an alternative is used in the 5 most similar protocols
MCF-7 and SK-BR-3 breast cancer cells were purchased from the American Type Culture Collection and cultured in Dulbecco's modified Eagle's medium (DMEM; Gibco; Thermo Fisher Scientific, Inc.) according to standard protocols. Mammospheres are one of the most commonly used breast cancer spherical models and are able to enrich CD44+/CD24−/low BCSLCs. MCF-7 (1×103 cells/ml) and SK-BR-3 cells (1×104 cells/ml) were cultured in suspension in serum-free DMEM-F12 (Gibco; Thermo Fisher Scientific, Inc.) supplemented with B27 (1:50; Gibco; Thermo Fisher Scientific, Inc.; cat. no. 17504-044), 20 ng/ml EGF recombinant human protein (Gibco; Thermo Fisher Scientific, Inc.; cat. no. PHG0311), 0.4% BSA (Sigma-Aldrich; Merck KGaA), 4 mg/ml insulin (Sigma-Aldrich; Merck KGaA) and penicillin-streptomycin (100X; Invitrogen; Thermo Fisher Scientific, Inc.). The cells were shaken twice a day, 20 times each time, to prevent adhesion to the flask walls. Mammospheres was apparent after 7–10 days (30 (link),31 (link)).
+ Open protocol
+ Expand
8

Hydrogel-based Cell Culture Platform

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dibenzocyclooctyne-sulfo-N-hydroxysuccinimidyl ester (DBCO-sulfo-NHS), dimethyl sulfoxide (DMSO), sodium hydroxide solution (1.0 N), agar, insulin, Triton-X, trypan blue solution, hyaluronidase type VI-S, collagenase type I, and resazurin based in vitro toxicology assay kit were purchased from Sigma-Aldrich (St. Louis, MO, USA). Phosphate-buffered saline (PBS) pH 7.4, 10× PBS, Slide-A-Lyzer dialysis kit (3.5k MWCO), collagen I bovine protein solution (5 mg mL−1), epidermal growth factor (EGF) recombinant human protein, fetal bovine serum (FBS), keratinocyte-serum free media (KSFM), bovine pyruvate extract (BPE), ITS Premix Universal Culture Supplement, trypsin, live/dead viability/cytotoxicity staining kit, paraformaldehyde (PFA), 5% normal goat serum, Alexa Fluor Phalloidin 488, Alexa Fluor 647-N-hydroxysuccinimidyl ester, and Alexa Fluor 546 secondary antibody were purchased from Thermo Fisher Scientific (Waltham, MA, USA). Azido-poly(ethylene glycol)5-N-hydroxysuccinimidyl ester (azido-PEG5-NHS) was purchased from BroadPharm (San Diego, CA, USA). Hyaluronate amine (40–50% degree of substitute) was purchased from Creative PEGWorks (Durham, NC, USA).
+ Open protocol
+ Expand
9

Cytoskeleton Modulating Compounds in Cell Biology

Check if the same lab product or an alternative is used in the 5 most similar protocols
Thapsigargin was obtained from Cayman Chemical (Ann Arbor, MI, United States). Colcemid was purchased from Merck (Darmstadt, Germany). Tubastatin A was obtained from BioVision (Milpitas, CA, United States). Nocodazole was purchased from Abcam (Cambridge, United Kingdom). Fura-2/AM was obtained from Invitrogen. EGF Recombinant Human Protein was purchased from Thermo Fisher (Thermo Fisher Scientific, Waltham, MA, United States). The antibodies used in this study are shown in Supplementary Table 3.
+ Open protocol
+ Expand
10

Piperlongumine-induced Oxidative Stress and Inflammation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Piperlongumine (PPL) was purchased from AK Scientific California, USA. EGF recombinant human protein was purchased from Thermo Fisher Scientific, USA. MTT, AO, EB, DAPI, DCFDA, JC-1, LPS from Escherichia coli, protease inhibitor cocktail, Poly-L-lysine solution, FragEL™ DNA Fragmentation Detection Kit, and Fluorescent-TdT Enzyme Assay Kit were procured from Sigma-Aldrich, USA. Protein A/G Magnetic Beads were purchased from Invitrogen, USA. IMQ cream, 5% w/w was purchased from Glenmark Pharmaceuticals India. Nitrocellulose membrane, ECL reagent, and protein dual marker were procured from Bio-Rad, USA. MILLIPLEX MAP Kit was obtained from Millipore, Germany. Enzyme-linked immunosorbent assay kits for IL-1β, IL-6, IL-17A, IL-22, TNF-α, and TGF-β were procured from Thermo Fisher Scientific, USA. All the chemicals used in the present study were pure and of analytical grade.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!